Clinical Trial Update: Real-World Effectiveness of Mavacamten in Canada

View source ↗

Summary

A real-world effectiveness study of mavacamten in Canada has completed, reporting observational data on its use for obstructive hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Mavacamten (mavacamten)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM) | Status: COMPLETED